🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study was to evaluate the safety and tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00865904
This will be a double-blind, randomized, placebo-controlled, parallel group...
Status
Completed
Location
University of Alabama
Start Date
2015-11
Trial ID
NCT02589236
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo-controlled, multicente...
Status
Completed
Location
University Medical Center, Utrecht, Department of Pulmonology and Tuberculosis
Start Date
2017-01-31
Trial ID
NCT03061331
The primary objective of the study was to evaluate the efficacy of lumacaft...
Status
Completed
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01807949
Treatments Being Tested
This study is designed to evaluate the effect of multiple doses of lumacaft...
Status
Completed
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01910415
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of treatme...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02709109
Treatments Being Tested
To evaluate the efficacy and safety of lumacaftor in combination with ivaca...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02514473
This study will explore the impact of lumacaftor/ivacaftor (LUM/IVA) on dis...
Status
Completed
Location
Charite Paediatric Pulmonology Department
Start Date
2018-08-10
Trial ID
NCT03625466
The purpose of this study is to assess the pharmacokinetics and safety of V...
Status
Completed
Location
PRA
Start Date
2010-10
Trial ID
NCT01216046
Treatments Being Tested
This is a Phase 4, randomized, double-blind, placebo-controlled, parallel-g...
Status
Completed
Location
Multiple Locations
Start Date
2016-09
Trial ID
NCT02875366